Glycosyltransferase B4GALNT2 as a Predictor of Good Prognosis in Colon Cancer: Lessons from Databases

Abstract

high <i>B4GALNT2</i> expression is a strong predictor of good prognosis in CRC as a part of a wider molecular signature that includes <i>ZG16</i>, <i>ITLN1</i>, <i>BEST2</i>, and <i>GUCA2B</i>. Differential DNA methylation and miRNA expression contribute to regulating <i>B4GALNT2</i> expression during colorectal carcinogenesis.